Cubist Systematic Strategies’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-50,395
| Closed | -$5.73M | – | 3207 |
|
|
2025
Q2 | $5.59M | Sell |
50,395
-20,291
| -29% | -$2.16M | 0.03% | 953 |
|
|
2025
Q1 | $7.92M | Buy |
70,686
+42,924
| +155% | +$4.43M | 0.05% | 617 |
|
|
2024
Q4 | $2.56M | Buy |
+27,762
| New | +$2.5M | 0.02% | 1213 |
|
|
2024
Q3 | – | Sell |
-241,686
| Closed | -$18.4M | – | 3175 |
|
|
2024
Q2 | $16.6M | Sell |
241,686
-8,801
| -4% | -$587K | 0.11% | 201 |
|
|
2024
Q1 | $18.3M | Buy |
250,487
+179,417
| +252% | +$13.8M | 0.1% | 218 |
|
|
2023
Q4 | $5.76M | Buy |
71,070
+61,722
| +660% | +$4.8M | 0.04% | 786 |
|
|
2023
Q3 | $701K | Buy |
+9,348
| New | +$719K | 0.01% | 2108 |
|
|
2023
Q2 | – | Sell |
-220,831
| Closed | -$17.6M | – | 3808 |
|
|
2023
Q1 | $18.3M | Sell |
220,831
-261,714
| -54% | -$21.7M | 0.11% | 183 |
|
|
2022
Q4 | $41.4M | Sell |
482,545
-59,335
| -11% | -$4.7M | 0.24% | 14 |
|
|
2022
Q3 | $33.4M | Buy |
541,880
+265,585
| +96% | +$16.7M | 0.19% | 35 |
|
|
2022
Q2 | $17.1M | Sell |
276,295
-197,953
| -42% | -$12.3M | 0.1% | 187 |
|
|
2022
Q1 | $28.2M | Buy |
474,248
+349,488
| +280% | +$22.3M | 0.24% | 19 |
|
|
2021
Q4 | $9.06M | Buy |
124,760
+48,154
| +63% | +$3.32M | 0.09% | 292 |
|
|
2021
Q3 | $5.35M | Sell |
76,606
-55,320
| -42% | -$3.89M | 0.07% | 433 |
|
|
2021
Q2 | $9.08M | Buy |
131,926
+3,520
| +3% | +$235K | 0.1% | 260 |
|
|
2021
Q1 | $8.3M | Buy |
128,406
+6,552
| +5% | +$422K | 0.11% | 223 |
|
|
2020
Q4 | $7.1M | Buy |
121,854
+40,856
| +50% | +$2.47M | 0.1% | 276 |
|
|
2020
Q3 | $5.12M | Buy |
80,998
+63,588
| +365% | +$4.41M | 0.08% | 403 |
|
|
2020
Q2 | $1.34M | Sell |
17,410
-28,056
| -62% | -$2.15M | 0.02% | 1010 |
|
|
2020
Q1 | $3.4M | Sell |
45,466
-41,816
| -48% | -$2.89M | 0.09% | 276 |
|
|
2019
Q4 | $5.67M | Sell |
87,282
-118,383
| -58% | -$7.71M | 0.1% | 260 |
|
|
2019
Q3 | $13M | Sell |
205,665
-35,292
| -15% | -$2.31M | 0.26% | 73 |
|
|
2019
Q2 | $16.3M | Buy |
240,957
+182,921
| +315% | +$12M | 0.3% | 43 |
|
|
2019
Q1 | $3.77M | Sell |
58,036
-78,500
| -57% | -$5.22M | 0.12% | 213 |
|
|
2018
Q4 | $8.54M | Buy |
136,536
+124,627
| +1,046% | +$8.71M | 0.4% | 15 |
|
|
2018
Q3 | $919K | Sell |
11,909
-4,660
| -28% | -$352K | 0.05% | 510 |
|
|
2018
Q2 | $1.17M | Sell |
16,569
-646
| -4% | -$45.6K | 0.06% | 418 |
|
|
2018
Q1 | $1.3M | Buy |
17,215
+8,838
| +106% | +$703K | 0.08% | 341 |
|
|
2017
Q4 | $600K | Sell |
8,377
-14,589
| -64% | -$1.11M | 0.03% | 772 |
|
|
2017
Q3 | $1.86M | Buy |
22,966
+12,460
| +119% | +$953K | 0.1% | 195 |
|
|
2017
Q2 | $744K | Buy |
10,506
+4,507
| +75% | +$300K | 0.05% | 555 |
|
|
2017
Q1 | $407K | Sell |
5,999
-14,055
| -70% | -$988K | 0.03% | 754 |
|
|
2016
Q4 | $1.44M | Buy |
20,054
+13,089
| +188% | +$973K | 0.11% | 237 |
|
|
2016
Q3 | $551K | Sell |
6,965
-31,661
| -82% | -$2.57M | 0.04% | 669 |
|
|
2016
Q2 | $3.22M | Buy |
38,626
+21,699
| +128% | +$1.93M | 0.19% | 101 |
|
|
2016
Q1 | $1.55M | Sell |
16,927
-41,501
| -71% | -$3.74M | 0.09% | 300 |
|
|
2015
Q4 | $5.91M | Buy |
58,428
+25,272
| +76% | +$2.63M | 0.35% | 31 |
|
|
2015
Q3 | $3.26M | Sell |
33,156
-5,945
| -15% | -$660K | 0.16% | 114 |
|
|
2015
Q2 | $4.58M | Sell |
39,101
-97,628
| -71% | -$10.7M | 0.22% | 80 |
|
|
2015
Q1 | $13.4M | Sell |
136,729
-21,103
| -13% | -$2.14M | 0.66% | 1 |
|
|
2014
Q4 | $14.9M | Buy |
157,832
+118,185
| +298% | +$12.2M | 0.8% | 2 |
|
|
2014
Q3 | $4.22M | Sell |
39,647
-14,332
| -27% | -$1.4M | 0.26% | 60 |
|
|
2014
Q2 | $4.47M | Buy |
+53,979
| New | +$4.2M | 0.27% | 62 |
|
Other funds holding GILD
Cubist Systematic Strategies's GILD Position: Q3 2025 in Review
Cubist Systematic Strategies sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 50,395 shares — an estimated $5.73M sold.
Cubist Systematic Strategies first reported a position in GILD in Q2 2014 and held it in 43 quarters. The position peaked at $41.4M in Q4 2022. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Cubist Systematic Strategies reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 50,395 Gilead Sciences shares in Q3 2025, an estimated $5.73M.
- Cubist Systematic Strategies first reported a position in Gilead Sciences in Q2 2014 and held it in 43 quarters.
- Cubist Systematic Strategies's Gilead Sciences position peaked at $41.4M in Q4 2022.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.